Within the past five years, RNA technologies have demonstrated they can improve patients’ health by transforming gene expression and open a successful new frontier for infectious disease vaccine development as seen fighting COVID-19. Companies are pushing RNA-based therapeutics into new tissues of the body beyond the liver and expanding vaccine programs to fight cancer and non-infectious diseases. This session will map out the RNA technology pipelines demonstrating clinical progress and feature experts describing the R&D hurdles they are still working to overcome.